News Conference News EuroPCR 2023 ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure Todd Neale May 18, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EHRA 2023 ‘Marshall Plan’ Ablation Superior to Pulmonary Vein Isolation in Persistent AF Michael O'Riordan April 20, 2023
News Daily News SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO Todd Neale March 28, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Conference News ACC 2023 PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF Todd Neale March 06, 2023
News Daily News Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults Michael O'Riordan February 09, 2023
News Conference News ISC 2023 Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke Todd Neale February 08, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2022 Shelley Wood January 03, 2023
News Daily News Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes Yael L. Maxwell December 06, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF Caitlin E. Cox October 27, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022